And the "one or two deals" the CEO talked about in August as perhaps coming in the next "several months." That's not to mention the potential of a buyout for RVX-208 or the whole company. The CEO indicated in January that these deals are "money deals." I think the potential for a deal or two this year is very good. Strong results in ASSURE will mean that this will be a very coveted drug program for Pharma. IMHO.
We are also expecting SUSTAIN's full results to be shared via a peer reviewed article - perhaps over the summer. That's another event to plan upon.
This stock has a lot of important news developing over the next several months.